You are here: Home » 2021 » March » Archives for 23rd

Zapata Computing and KAUST Partner to Bring Quantum Computing to the Middle East for the Advancement of Computational Fluid Dynamics

BOSTON, March 23, 2021 (GLOBE NEWSWIRE) — Zapata Computing, Inc., the leading enterprise software company for NISQ–based quantum applications, today announced a new partnership with Middle East–based King Abdullah University of Science and Technology (KAUST) to be a licensed user of Zapata's Orquestra , the modular, workflow–based platform for applied quantum computing. KAUST is examining various lines of research to determine how quantum technologies could represent an advantage over classical compute tools in a variety of Computational Fluid Dynamics (CFD) use cases for airplane and automobile aerodynamic design.

Currently, CFD computations are extremely time–consuming and expensive to run. The simulation process is inefficient, and a lot of time is wasted trying to model air flow around wings and engines more efficiently. Boosting work around those designs could allow manufacturers to build more energy–efficient airplanes and lead to lowered carbon emissions for air travel "" therefore, having an enormous positive impact on the environment. Airplane transportation is overall responsible for 2% of greenhouse gas emissions. For airlines and plane manufacturers this could drive meaningful financial and environmental results "" all supported by new quantum technology.

Home to the KAUST Research and Technology Park (KRTP) where R&D centers, corporates and start–ups choose to locate themselves, the university has a track record of collaborating with industry partners at national and international levels to transfer research–based technology into the market to achieve public benefit.

"We are delighted to be the catalyst for bringing quantum capabilities to CFD research in the Kingdom of Saudi Arabia and to the Middle East," said Kevin Cullen, vice president of Innovation and Economic Development at KAUST. "This partnership establishes Zapata as one of the first quantum computing companies active in the region and will enable KAUST researchers to explore the future of aerospace fluid dynamics. KAUST is a leader in the areas of data analysis and AI and we welcome the addition of Zapata's Orquestra technology to our capabilities, in order to accelerate discovery and innovation in these fields."

Zapata's Orquestra platform improves data analytics performance, empowering companies and research organizations to build quantum–enabled workflows , execute them across the full range of quantum and classical devices, and then collect and analyze resulting data. With Orquestra, organizations can leverage quantum capabilities to generate augmented data sets, speed up data analysis, and construct better data models for a range of applications. Importantly, it provides organizations with the most flexible, applied toolset in quantum computing so that its users can build quantum capabilities without getting locked in with a single vendor or architecture in the next several years.

"We are always looking to expand quantum computing use cases through Orquestra and our work with KAUST will give us a head start to explore new opportunities for more efficient CFD," said Christopher Savoie, co–founder and CEO, Zapata. "The collaboration with KAUST will benefit the aerospace industry as a whole by using quantum to bring efficiency to what has historically been a slow and difficult process."

About Zapata Computing
Zapata Computing, Inc. builds quantum–ready applications for enterprise deployment through our flagship product Orquestra "" the only workflow–based toolset for enterprise quantum computing. Zapata has pioneered a new quantum–classical development and deployment paradigm that focuses on a range of use cases, including ML, optimization and simulation. Orquestra integrates best–in–class classical and quantum technologies including Zapata's leading–edge algorithms, open–source libraries in Python and Julia, and more. Zapata partners closely with hardware providers across the quantum ecosystem such as Amazon, Google, Honeywell, IBM, IonQ, Microsoft and Rigetti. Investors include BASF Venture Capital, Honeywell Ventures, Itochu Corporation and Merck Global Health. Enterprise customers include Merck, BP, BBVA, KAUST and Coca Cola Bottlers Japan Inc., among others.

For more information visit www.ZapataComputing.com and www.Orquestra.io.

About KAUST
Established in 2009, King Abdullah University of Science and Technology (KAUST) is a graduate research university devoted to finding solutions for some of the world's most pressing scientific and technological challenges in the areas of food, water, energy and the environment. With 19 research areas related to these themes and state of the art labs, KAUST has created a collaborative and interdisciplinary problem–solving environment, which has resulted in over 11,000 published papers to date.

With over 100 different nationalities living, working and studying on campus, KAUST has brought together the best minds and ideas from around the world with the goal of advancing science and technology through distinctive and collaborative research. KAUST is a catalyst for innovation, economic development and social prosperity in Saudi Arabia and the world. For additional information, visit: www.Kaust.edu.sa

Media Contact:
Anya Nelson
Scratch Marketing + Media for Zapata Computing
anyan@scratchmm.com
617.817.6559


GLOBENEWSWIRE (Distribution ID 8204570)

Fortem Technologies and Toshiba Announce Strategic Alliance

Pleasant Grove, UT and Kawasaki, March 23, 2021 (GLOBE NEWSWIRE) — Fortem Technologies, Inc., a leader in airspace security and defense for detecting and defeating dangerous drones, announced today that Toshiba Infrastructure Systems & Solutions (hereafter Toshiba) has invested $15 million USD in the company and that they have formed a strategic business alliance. The two companies will integrate their highly complementary systems and expand sales around the world.

The Fortem SkyDome System is a highly accurate drone detection solution based on Fortem TrueView radars that are easy to install and effective in urban environments. Also part of the system, Fortem DroneHunter is an AI–enabled autonomous drone that can safely capture and remove rogue drones day and night.

Toshiba has already commercialized a drone detection system that can determine the incoming direction and altitude of a drone by receiving radio waves emitted by the drone in flight. "Toshiba is also strengthening the drone security business by its own research and development of related products.

"Toshiba is a world–renowned technical and sales powerhouse," said Timothy Bean, CEO of Fortem Technologies, Inc. "We are very pleased to announce this alliance to accelerate the delivery of solutions to our customers that combine the disruptive innovation of our AI–enabled Fortem SkyDome System with the depth of Toshiba's commercial drone RF detection expertise and advanced radar technology. This partnership brings added confidence to security professionals who must secure the airspace above their venues, campuses and metro regions."

Masaki Haruyama, Vice President of Toshiba said, "We are excited to partner with Fortem, a pioneering counter–drone solution provider with a proven detection system and unique and highly effective mitigation system. Toshiba has a long history of providing leading technologies of radars. With the perfectly complementary technologies and products of the two companies, we are confident that we can become a global top–tier player in a rapidly growing market, and contribute to safer, more reliable facilities."

About Toshiba Infrastructure Systems & Solutions Corporation

Toshiba Infrastructure Systems & Solutions Corporation is the core company promoting Toshiba Group's business in social infrastructure. Split off from Toshiba Corporation (Tokyo: 6502) in 2017, the company is based in Kawasaki with revenue of over 730 billion JPY in 2019 and more than 18,000 employees. For more than 80 years, Toshiba Group has been providing advanced radars and other innovative technologies that have contributed to a safe, more secure and reliable world. Security solution business including counter drone systems is one of its focusing markets.

For more information, please visit https://www.toshiba.co.jp/infrastructure/en/index.htm

About Fortem Technologies, Inc.

Fortem Technologies is a leader in airspace security and defense for detecting and defeating dangerous drones. Through an advanced ecosystem of distributed radar, AI at–the–edge, deep sensor integration and autonomous drone capture, Fortem SkyDome monitors, protects, and defends the world's corridors, venues, infrastructures, borders, and regions from dangerous or malicious drone threats. The same ecosystem is accelerating the safety of the world's airspace for urban air mobility. Based in Pleasant Grove, Utah, the company is privately held and backed by Boeing HorizonX Global Ventures, DCVC, Mubadala Investment Company, Signia Venture Partners, and others. For more information, please visit www.fortemtech.com.


GLOBENEWSWIRE (Distribution ID 8204368)

FXCM named Best Zero Commission Broker at ADVFN Awards 2021

LONDON and SYDNEY, Australia and JOHANNESBURG, South Africa, March 23, 2021 (GLOBE NEWSWIRE) — FXCM Group, LLC ("FXCM Group' or "FXCM'), the leading international provider of online foreign exchange trading, CFD trading and related services, announced today that they have been named the Best Zero Commission* Broker in the ADVFN International Financial Awards 2021.

FXCM was awarded the nomination by a panel of judges from ADVFN, a leading global stocks and shares information website. Having only launched the zero–commission CFD shares trading under a year ago, the award is a testament to the success and appeal of FXCM's offering in bringing the most sought–after trading opportunities.

Over the course of last year, FXCM has broadened its offering with a range of new instruments and trading opportunities. Enabling zero–commission trading was a key part of this expansion and in increasing the ease of market access for retail investors during the unprecedented volatility brought by the global pandemic.

Brendan Callan, CEO of FXCM said: "Being named Best Zero Commission Broker by ADVFN is a hugely rewarding acknowledgement of our team's hard work, especially on such a recent update in our offering. There's clearly a growing expectation from traders for more affordable investing opportunities, and that's the cornerstone of our approach. It's been a really exciting few months for retail investors and this award is complement to our efforts in providing our clients with some of the best opportunities to capitalise on today's volatility."

*FXCM can be compensated in several ways, which includes but are not limited to adding a mark–up to the spreads it receives from its liquidity providers, adding a mark–up to rollover, etc. Commission–based pricing is applicable to Active Trader account types.

About FXCM:

FXCM is a leading provider of online foreign exchange (FX) trading, CFD trading, and related services. Founded in 1999, the company's mission is to provide global traders with access to the world's largest and most liquid market by offering innovative trading tools, hiring excellent trading educators, meeting strict financial standards and striving for the best online trading experience in the market. Clients have the advantage of mobile trading, one–click order execution and trading from real–time charts. In addition, FXCM offers educational courses on FX trading and provides trading tools, proprietary data and premium resources. FXCM Pro provides retail brokers, small hedge funds and emerging market banks access to wholesale execution and liquidity, while providing high and medium frequency funds access to prime brokerage services via FXCM Prime. FXCM is a Leucadia Company.

Trading Forex/CFDs on margin carries a high level of risk and may not be suitable for all investors. Leverage can work against you. The products are intended for retail, professional and eligible counterparty clients. Retail clients who maintain account(s) with Forex Capital Markets Limited (“FXCM LTD”), could sustain a total loss of deposited funds but are not subject to subsequent payment obligations beyond the deposited funds but professional clients and eligible counterparty clients could sustain losses in excess of deposits. Prior to trading any products offered by Forex Capital Markets Limited, inclusive of all EU branches, FXCM Australia Pty. Limited, FXCM South Africa (PTY) Ltd, any affiliates of aforementioned firms, or other firms within the FXCM group of companies [collectively the “FXCM Group”], carefully consider your financial situation and experience level. If you decide to trade products offered by FXCM Australia Pty. Limited ("FXCM AU") (AFSL 309763), you must read and understand the Financial Services Guide, Product Disclosure Statement, and Terms of Business. Our FX and CFD prices are set by us, are not made on an Exchange and are not governed under the Financial Advisory and Intermediary Services Act. The FXCM Group may provide general commentary, which is not intended as investment advice and must not be construed as such. Seek advice from a separate financial advisor. The FXCM Group assumes no liability for errors, inaccuracies or omissions; does not warrant the accuracy, completeness of information, text, graphics, links or other items contained within these materials. Read and understand the Terms and Conditions on the FXCM Group's websites prior to taking further action.

Read full disclaimer

Media contact:

Chatsworth Communications
+44 (0) 20 7440 9780
fxcm@chatsworthcommunications.com


GLOBENEWSWIRE (Distribution ID 8204220)

Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies

Lead product candidate, ZB001, has first–in–class potential in China for Thyroid Eye Disease

Rapidly advancing seven pipeline programs, including three worldwide, with best–in–class potential in autoimmune and rare diseases

Expanding a proven leadership team of veteran life science industry executives

Company founded and initially funded by Tellus BioVentures and Fairmount

HONG KONG and BOSTON, March 23, 2021 (GLOBE NEWSWIRE) — Zenas BioPharma ("Zenas") launched today as a cross–border biopharmaceutical company committed to becoming a global leader in the development and delivery of immune–based therapies for patients in China and throughout the world.

Zenas was founded and initially funded by Tellus BioVentures, LLC ("Tellus") and Fairmount Funds Management LLC ("Fairmount") and is additionally backed by a syndicate of leading global life science investment funds including Quan Capital, WuXi Biologics Healthcare Ventures and Wellington Management.

Lonnie Moulder, Managing Member of Tellus and Founder of Zenas, serves as Executive Chairman and Interim Chief Executive Officer. As a veteran life sciences founder and executive, he brings to Zenas a track record of success and the necessary skills to navigate the global biopharmaceutical landscape. Mr. Moulder has assembled an experienced leadership team with strong credentials in acquiring, developing and commercializing products across the globe.

"We are excited about the launch of Zenas BioPharma and its pipeline of differentiated product candidates. These potentially best–in–class products are intended to bring innovation to patients with underserved diagnoses while also maximizing value across the healthcare ecosystem," said Mr. Moulder. "The expanding Zenas leadership team and our network of business partners will drive operational excellence to deliver potentially transformative therapies to improve the lives of people living with autoimmune and rare diseases."

"We are thrilled to invest in and support this new venture lead by a proven and experienced team," added Marietta Wu, MD, Ph.D., MBA, Managing Director at Quan Capital and Zenas Board Member. "Immunology is an area of transformative innovation poised to solve great unmet medical needs. We are confident that by leveraging cross border research and development capabilities and resources, Zenas will rapidly advance its current portfolio and establish its global leadership with an expanded pipeline coupled with a strong footprint in China."

Rapidly Advancing Pipeline

Zenas debuts with a deep pipeline of seven innovative immune–based therapeutics that will continue to expand through a successful business development strategy. Zenas owns worldwide rights to three of the seven pipeline programs, which uniquely positions the Company to be global in scope.

Zenas innovation is defined by the selection of product candidates that are designed with best–in–class potential and then advanced utilizing differentiated development and commercial strategies to address patient needs AND the value requirements of the dynamic healthcare environment. Zenas innovation further includes acquiring or discovering first–in–class product candidates based upon new knowledge in the evolving field of immunology.

ZB001 and ZB011

Zenas is developing its lead product candidate ZB001, an insulin–like growth factor–1 receptor (IGF1R) monoclonal antibody (mAb), for the potential treatment of patients in China with thyroid eye disease (TED). TED is a debilitating condition that significantly impacts quality of life and can cause proptosis ("bulging eyes"), double vision and vision loss. ZB001, a potential first–in–class product in China, was exclusively in–licensed from Viridian Therapeutics, Inc. ("Viridian") (NASDAQ: VRDN).

More than 100 oncology patients have previously been treated with the antibody in US and EU studies, under the name AVE–1642, enabling understanding of its pharmacokinetic and pharmacodynamic profile, as well as its safety and tolerability. Viridian maintains all rights outside of China and is developing the IGF1R mAb under the name VRDN–001. This program is advancing rapidly with an expected Investigational New Drug ("IND") application filing by Viridian in late 2021, followed by a Zenas filing in China. Data from the first clinical trial involving patients is expected to be available in 2022.

In parallel with ZB001 development, Viridian and Zenas initiated the ZB011 program, which seeks to improve IGF1R–targeted antibodies to further enhance dosing and convenience.

ZB002, ZB003 and ZB004

The Zenas pipeline also includes three potentially best–in–class mAbs (ZB002, ZB003, ZB004) exclusively in–licensed worldwide from Xencor, Inc. (NASDAQ: XNCR). These three mAbs were engineered with XmAb technology for improved potency, half–life, and stability and are undergoing IND–enabling studies to support clinical development for both new and established autoimmune disease indications.

ZB005 and ZB006

Zenas additionally entered a collaboration with Dianthus Therapeutics, Inc. ("Dianthus") that provides China rights for two mAb programs, ZB005 and ZB006. Dianthus is a privately held biotechnology company focused on the discovery and development of monoclonal antibody therapeutics that modulate the immune complement system for the treatment of autoimmune diseases. IND–enabling activities are underway for ZB005, the first of the two programs.

About Zenas BioPharma

Zenas BioPharma is a cross–border (China–USA based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune–based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Contacts

Investor Contact:

Zenas BioPharma
IR@zenasbio.com

Media Contact:

Lauren Bartlett
Zenas BioPharma
lauren.bartlett@zenasbio.com


GLOBENEWSWIRE (Distribution ID 8193523)

LeddarTech Announces Participation at Multiple Major Digital Events Focused on ADAS and AD in April 2021

QUEBEC CITY, March 23, 2021 (GLOBE NEWSWIRE) — LeddarTech , a global leader in Level 1–5 ADAS and AD sensing technology, will participate in several global digital events in April as an exhibitor, presenter, as well as sponsor. The company will showcase its comprehensive end–to–end technology platforms that enable customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility markets. These featured solutions include the LeddarVision sensor–fusion and perception platform and the cost–effective, scalable LiDAR development platform based on patented LeddarEngine technology.

"LeddarTech continually seeks opportunities to bring our customers, partners, and other industry organizations together to share our unique platform business model as well as network on new developments and solutions to address today's ADAs and AD opportunities," stated Daniel Aitken, Vice–President of Global Marketing, Communications, and Product Management. "Our participation in these major digital forums is a reflection of this philosophy, and we look forward to the opportunity to meet customers and organizations who are also committed to driving autonomy and the increased safety aspects that it provides," concluded Mr. Aitken.

ADAS Sensors 2021 Online "" April 6–8 (Detroit, USA)

Advanced driver assistance systems (ADAS) require numerous sensing modalities and advanced sensor data fusion and perception capabilities to accurately perform constant assessments through detection to respond safely to driving situations that may arise. The ADAS market is expected to reach $84 billion in 2025. What is driving this growth, and what technology demands will shape the subsequent developments? Join LeddarTech at ADAS Sensors Online 2021 to find out.

  • Featured presentation: "Sensing Modalities, Perception, and Fusion Technology Trends for ADAS Applications," by Pierre Olivier, LeddarTech's Chief Technology Officer, April 6 @ 11:50 a.m. –12:20 p.m. ET
  • Virtual booth: LeddarTech will showcase its market–defining sensing and perception solutions for ADAS and AD applications, including the LeddarVision platform and various sensing components and software. Also on display will be STMicroelectronics' MEMS mirror–based scanning solutions for LiDARs. Our technical representatives will be available online throughout the event.
  • Register here

Hannover Messe Digital Edition "" April 12–16 (Hannover, Germany)

This year, the illustrious Hannover Messe expo and mega–conference will be digital. LeddarTech will be a co–exhibitor at the Quebec pavilion in association with Investissement Qubec, whose mission is to play an active role in Qubec's economic development by spurring business innovation, entrepreneurship, and business acquisitions, as well as growth in investment and exports. LeddarTech can be found at the Kiosque Entreprise for the duration of the event.

Register now at hannovermesse.de/en/conference/

AutoTech Council – Innovation Review on Connected Cars "" April 15 (North America)

  • This Autotech Council event will focus on the new technologies and innovations that enable the connected cars of today and the future and introduce attendees to entrepreneurs that are making this future a reality. Join OEMs, suppliers, startups, and VCs to discuss hot topics such as 5G, embedded vs. tethered connectivity, personal data and privacy, big data analytics, value–added services, and much more. Pierre Olivier, LeddarTech's Chief Technology Officer, will participate in the panel discussion taking place April 15 from 8:55 a.m. to 9:25 a.m. PT.
  • Register here

6th Automotive Sensors and Electronics Summit "" April 28 (Munich, Germany)

The Automotive Sensors and Electronics Summit is an annual event that consistently attracts key decision–makers across various industry sectors. This event has an outstanding reputation in the automotive sensors and electronics community to highlight emerging technologies and support valuable networking opportunities.

  • Case study presentation: "Sensor–Fusion and Perception Solutions for Key ADAS and AD Applications," by Michael Poulin, Vice–President, Strategic Partnerships and Corporate Development, April 28, 2021 @ 4:30 p.m. CET
  • Featured e–book: LeddarVision Sensor Fusion and Perception Technology
  • Register here

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end–to–end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision sensor–fusion and perception platform and its cost–effective, scalable, and versatile LiDAR development solution for automotive–grade solid–state LiDARs based on the LeddarEngine, LeddarTech enables Tier 1–2 automotive system integrators to develop full–stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting–edge automotive and mobility remote–sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice–President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1–418–653–9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owner


GLOBENEWSWIRE (Distribution ID 8193302)